This inventor holds 1 USPTO granted patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Xiaoxi Liu
Introduction
Xiaoxi Liu is a prominent inventor known for her significant contributions to the field of cancer research. She has made strides in developing novel therapeutic approaches for treating multiple myeloma, a type of blood cancer. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Xiaoxi Liu holds a patent for "Novel USP7 Inhibitors for Treating Multiple Myeloma." This innovative approach targets specific pathways involved in cancer progression, showcasing her dedication to finding effective treatments for challenging diseases. She has 1 patent to her name, reflecting her impactful contributions to the scientific community.
Career Highlights
Currently, Xiaoxi Liu is affiliated with the Dana-Farber Cancer Institute, where she continues her research and development efforts. Her work at this prestigious institution allows her to collaborate with leading experts in oncology and contribute to groundbreaking studies aimed at improving cancer therapies.
Collaborations
Due to space constraints, the details of her collaborations will not be included.
Conclusion
Xiaoxi Liu's innovative work in developing novel USP7 inhibitors exemplifies her commitment to advancing cancer treatment. Her contributions are vital in the ongoing fight against multiple myeloma, and her research continues to inspire future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile